Industry Research Reports

Home > Reports > Medical Devices & Consumables > Blood-based Biomarker - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Blood-based Biomarker - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Medical Devices & Consumables

Published Date: 2025-03-28

Pages: 101 Pages

Report ld: 4694957

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Blood-based Biomarker Market Size(US$)

CAGR 2025-2031

10.4%

Market Size,2031

USD 3,638

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 2,015 million

Market Forecast in 2031(Value)

US$ 3,638 million

CAGR

10.4%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Blood-based Biomarker was estimated to be worth US$ 1867 million in 2024 and is forecast to a readjusted size of US$ 3638 million by 2031 with a CAGR of 10.4% during the forecast period 2025-2031.

A blood-based biomarker is a measurable biological molecule found in the blood that indicates normal or pathological processes in the body. These biomarkers can be proteins, nucleic acids, metabolites, or even circulating tumor cells that help diagnose diseases, monitor treatment responses, and predict patient outcomes. Blood-based biomarkers are widely used in oncology, neurology, and cardiovascular diseases, enabling early detection and personalized medicine approaches. Their non-invasive nature makes them highly valuable for routine clinical practice and research.

North American market for Blood-based Biomarker was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Blood-based Biomarker was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Blood-based Biomarker was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global key companies of Blood-based Biomarker include Roche Diagnostics, Thermo Fisher Scientific, Bio-Rad Laboratories, Qiagen, Abbott, Siemens Healthineers, Danaher, Quidel Corporation, Grifols, Biocartis, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Blood-based Biomarker, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Blood-based Biomarker by region & country, by Type, and by Application.

The Blood-based Biomarker market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood-based Biomarker.

MARKET SEGMENTATION

By Company

Roche Diagnostics
Thermo Fisher Scientific
Bio-Rad Laboratories
Qiagen
Abbott
Siemens Healthineers
Danaher
Quidel Corporation
Grifols
Biocartis
Vernalis
Labcorp Drug Development

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Next Generation Sequencing
Mass Spectrometry
Liquid Biopsy Technologies

Segment by Application

Hospital
Diagnostic Centers
Research Labs

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Blood-based Biomarker company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Blood-based Biomarker in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Blood-based Biomarker in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Blood-based Biomarker Product Introduction

1.2 Global Blood-based Biomarker Market Size Forecast (2020-2031)

1.3 Blood-based Biomarker Market Trends & Drivers

1.3.1 Blood-based Biomarker Industry Trends

1.3.2 Blood-based Biomarker Market Drivers & Opportunity

1.3.3 Blood-based Biomarker Market Challenges

1.3.4 Blood-based Biomarker Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Blood-based Biomarker Players Revenue Ranking (2024)

2.2 Global Blood-based Biomarker Revenue by Company (2020-2025)

2.3 Key Companies Blood-based Biomarker Manufacturing Base Distribution and Headquarters

2.4 Key Companies Blood-based Biomarker Product Offered

2.5 Key Companies Time to Begin Mass Production of Blood-based Biomarker

2.6 Blood-based Biomarker Market Competitive Analysis

2.6.1 Blood-based Biomarker Market Concentration Rate (2020-2025)

2.6.2 Global 5 and 10 Largest Companies by Blood-based Biomarker Revenue in 2024

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood-based Biomarker as of 2024)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Next Generation Sequencing

3.1.2 Mass Spectrometry

3.1.3 Liquid Biopsy Technologies

3.2 Global Blood-based Biomarker Sales Value by Type

3.2.1 Global Blood-based Biomarker Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Blood-based Biomarker Sales Value, by Type (2020-2031)

3.2.3 Global Blood-based Biomarker Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Diagnostic Centers

4.1.3 Research Labs

4.2 Global Blood-based Biomarker Sales Value by Application

4.2.1 Global Blood-based Biomarker Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Blood-based Biomarker Sales Value, by Application (2020-2031)

4.2.3 Global Blood-based Biomarker Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

5.1 Global Blood-based Biomarker Sales Value by Region

5.1.1 Global Blood-based Biomarker Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Blood-based Biomarker Sales Value by Region (2020-2025)

5.1.3 Global Blood-based Biomarker Sales Value by Region (2026-2031)

5.1.4 Global Blood-based Biomarker Sales Value by Region (%), (2020-2031)

5.2 North America

5.2.1 North America Blood-based Biomarker Sales Value, 2020-2031

5.2.2 North America Blood-based Biomarker Sales Value by Country (%), 2024 VS 2031

5.3 Europe

5.3.1 Europe Blood-based Biomarker Sales Value, 2020-2031

5.3.2 Europe Blood-based Biomarker Sales Value by Country (%), 2024 VS 2031

5.4 Asia Pacific

5.4.1 Asia Pacific Blood-based Biomarker Sales Value, 2020-2031

5.4.2 Asia Pacific Blood-based Biomarker Sales Value by Region (%), 2024 VS 2031

5.5 South America

5.5.1 South America Blood-based Biomarker Sales Value, 2020-2031

5.5.2 South America Blood-based Biomarker Sales Value by Country (%), 2024 VS 2031

5.6 Middle East & Africa

5.6.1 Middle East & Africa Blood-based Biomarker Sales Value, 2020-2031

5.6.2 Middle East & Africa Blood-based Biomarker Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Blood-based Biomarker Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Blood-based Biomarker Sales Value, 2020-2031

6.3 United States

6.3.1 United States Blood-based Biomarker Sales Value, 2020-2031

6.3.2 United States Blood-based Biomarker Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Blood-based Biomarker Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Blood-based Biomarker Sales Value, 2020-2031

6.4.2 Europe Blood-based Biomarker Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Blood-based Biomarker Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Blood-based Biomarker Sales Value, 2020-2031

6.5.2 China Blood-based Biomarker Sales Value by Type (%), 2024 VS 2031

6.5.3 China Blood-based Biomarker Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Blood-based Biomarker Sales Value, 2020-2031

6.6.2 Japan Blood-based Biomarker Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Blood-based Biomarker Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Blood-based Biomarker Sales Value, 2020-2031

6.7.2 South Korea Blood-based Biomarker Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Blood-based Biomarker Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Blood-based Biomarker Sales Value, 2020-2031

6.8.2 Southeast Asia Blood-based Biomarker Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Blood-based Biomarker Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Blood-based Biomarker Sales Value, 2020-2031

6.9.2 India Blood-based Biomarker Sales Value by Type (%), 2024 VS 2031

6.9.3 India Blood-based Biomarker Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 Roche Diagnostics

7.1.1 Roche Diagnostics Profile

7.1.2 Roche Diagnostics Main Business

7.1.3 Roche Diagnostics Blood-based Biomarker Products, Services and Solutions

7.1.4 Roche Diagnostics Blood-based Biomarker Revenue (US$ Million) & (2020-2025)

7.1.5 Roche Diagnostics Recent Developments

7.2 Thermo Fisher Scientific

7.2.1 Thermo Fisher Scientific Profile

7.2.2 Thermo Fisher Scientific Main Business

7.2.3 Thermo Fisher Scientific Blood-based Biomarker Products, Services and Solutions

7.2.4 Thermo Fisher Scientific Blood-based Biomarker Revenue (US$ Million) & (2020-2025)

7.2.5 Thermo Fisher Scientific Recent Developments

7.3 Bio-Rad Laboratories

7.3.1 Bio-Rad Laboratories Profile

7.3.2 Bio-Rad Laboratories Main Business

7.3.3 Bio-Rad Laboratories Blood-based Biomarker Products, Services and Solutions

7.3.4 Bio-Rad Laboratories Blood-based Biomarker Revenue (US$ Million) & (2020-2025)

7.3.5 Bio-Rad Laboratories Recent Developments

7.4 Qiagen

7.4.1 Qiagen Profile

7.4.2 Qiagen Main Business

7.4.3 Qiagen Blood-based Biomarker Products, Services and Solutions

7.4.4 Qiagen Blood-based Biomarker Revenue (US$ Million) & (2020-2025)

7.4.5 Qiagen Recent Developments

7.5 Abbott

7.5.1 Abbott Profile

7.5.2 Abbott Main Business

7.5.3 Abbott Blood-based Biomarker Products, Services and Solutions

7.5.4 Abbott Blood-based Biomarker Revenue (US$ Million) & (2020-2025)

7.5.5 Abbott Recent Developments

7.6 Siemens Healthineers

7.6.1 Siemens Healthineers Profile

7.6.2 Siemens Healthineers Main Business

7.6.3 Siemens Healthineers Blood-based Biomarker Products, Services and Solutions

7.6.4 Siemens Healthineers Blood-based Biomarker Revenue (US$ Million) & (2020-2025)

7.6.5 Siemens Healthineers Recent Developments

7.7 Danaher

7.7.1 Danaher Profile

7.7.2 Danaher Main Business

7.7.3 Danaher Blood-based Biomarker Products, Services and Solutions

7.7.4 Danaher Blood-based Biomarker Revenue (US$ Million) & (2020-2025)

7.7.5 Danaher Recent Developments

7.8 Quidel Corporation

7.8.1 Quidel Corporation Profile

7.8.2 Quidel Corporation Main Business

7.8.3 Quidel Corporation Blood-based Biomarker Products, Services and Solutions

7.8.4 Quidel Corporation Blood-based Biomarker Revenue (US$ Million) & (2020-2025)

7.8.5 Quidel Corporation Recent Developments

7.9 Grifols

7.9.1 Grifols Profile

7.9.2 Grifols Main Business

7.9.3 Grifols Blood-based Biomarker Products, Services and Solutions

7.9.4 Grifols Blood-based Biomarker Revenue (US$ Million) & (2020-2025)

7.9.5 Grifols Recent Developments

7.10 Biocartis

7.10.1 Biocartis Profile

7.10.2 Biocartis Main Business

7.10.3 Biocartis Blood-based Biomarker Products, Services and Solutions

7.10.4 Biocartis Blood-based Biomarker Revenue (US$ Million) & (2020-2025)

7.10.5 Biocartis Recent Developments

7.11 Vernalis

7.11.1 Vernalis Profile

7.11.2 Vernalis Main Business

7.11.3 Vernalis Blood-based Biomarker Products, Services and Solutions

7.11.4 Vernalis Blood-based Biomarker Revenue (US$ Million) & (2020-2025)

7.11.5 Vernalis Recent Developments

7.12 Labcorp Drug Development

7.12.1 Labcorp Drug Development Profile

7.12.2 Labcorp Drug Development Main Business

7.12.3 Labcorp Drug Development Blood-based Biomarker Products, Services and Solutions

7.12.4 Labcorp Drug Development Blood-based Biomarker Revenue (US$ Million) & (2020-2025)

7.12.5 Labcorp Drug Development Recent Developments

8 Industry Chain Analysis

8.1 Blood-based Biomarker Industrial Chain

8.2 Blood-based Biomarker Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Blood-based Biomarker Sales Model

8.5.2 Sales Channel

8.5.3 Blood-based Biomarker Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Blood-based Biomarker Market Trends

Table 2. Blood-based Biomarker Market Drivers & Opportunity

Table 3. Blood-based Biomarker Market Challenges

Table 4. Blood-based Biomarker Market Restraints

Table 5. Global Blood-based Biomarker Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Blood-based Biomarker Revenue Market Share by Company (2020-2025)

Table 7. Key Companies Blood-based Biomarker Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Blood-based Biomarker Product Type

Table 9. Key Companies Time to Begin Mass Production of Blood-based Biomarker

Table 10. Global Blood-based Biomarker Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood-based Biomarker as of 2024)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Blood-based Biomarker Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 14. Global Blood-based Biomarker Sales Value by Type (2020-2025) & (US$ Million)

Table 15. Global Blood-based Biomarker Sales Value by Type (2026-2031) & (US$ Million)

Table 16. Global Blood-based Biomarker Sales Market Share in Value by Type (2020-2025)

Table 17. Global Blood-based Biomarker Sales Market Share in Value by Type (2026-2031)

Table 18. Global Blood-based Biomarker Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 19. Global Blood-based Biomarker Sales Value by Application (2020-2025) & (US$ Million)

Table 20. Global Blood-based Biomarker Sales Value by Application (2026-2031) & (US$ Million)

Table 21. Global Blood-based Biomarker Sales Market Share in Value by Application (2020-2025)

Table 22. Global Blood-based Biomarker Sales Market Share in Value by Application (2026-2031)

Table 23. Global Blood-based Biomarker Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 24. Global Blood-based Biomarker Sales Value by Region (2020-2025) & (US$ Million)

Table 25. Global Blood-based Biomarker Sales Value by Region (2026-2031) & (US$ Million)

Table 26. Global Blood-based Biomarker Sales Value by Region (2020-2025) & (%)

Table 27. Global Blood-based Biomarker Sales Value by Region (2026-2031) & (%)

Table 28. Key Countries/Regions Blood-based Biomarker Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 29. Key Countries/Regions Blood-based Biomarker Sales Value, (2020-2025) & (US$ Million)

Table 30. Key Countries/Regions Blood-based Biomarker Sales Value, (2026-2031) & (US$ Million)

Table 31. Roche Diagnostics Basic Information List

Table 32. Roche Diagnostics Description and Business Overview

Table 33. Roche Diagnostics Blood-based Biomarker Products, Services and Solutions

Table 34. Revenue (US$ Million) in Blood-based Biomarker Business of Roche Diagnostics (2020-2025)

Table 35. Roche Diagnostics Recent Developments

Table 36. Thermo Fisher Scientific Basic Information List

Table 37. Thermo Fisher Scientific Description and Business Overview

Table 38. Thermo Fisher Scientific Blood-based Biomarker Products, Services and Solutions

Table 39. Revenue (US$ Million) in Blood-based Biomarker Business of Thermo Fisher Scientific (2020-2025)

Table 40. Thermo Fisher Scientific Recent Developments

Table 41. Bio-Rad Laboratories Basic Information List

Table 42. Bio-Rad Laboratories Description and Business Overview

Table 43. Bio-Rad Laboratories Blood-based Biomarker Products, Services and Solutions

Table 44. Revenue (US$ Million) in Blood-based Biomarker Business of Bio-Rad Laboratories (2020-2025)

Table 45. Bio-Rad Laboratories Recent Developments

Table 46. Qiagen Basic Information List

Table 47. Qiagen Description and Business Overview

Table 48. Qiagen Blood-based Biomarker Products, Services and Solutions

Table 49. Revenue (US$ Million) in Blood-based Biomarker Business of Qiagen (2020-2025)

Table 50. Qiagen Recent Developments

Table 51. Abbott Basic Information List

Table 52. Abbott Description and Business Overview

Table 53. Abbott Blood-based Biomarker Products, Services and Solutions

Table 54. Revenue (US$ Million) in Blood-based Biomarker Business of Abbott (2020-2025)

Table 55. Abbott Recent Developments

Table 56. Siemens Healthineers Basic Information List

Table 57. Siemens Healthineers Description and Business Overview

Table 58. Siemens Healthineers Blood-based Biomarker Products, Services and Solutions

Table 59. Revenue (US$ Million) in Blood-based Biomarker Business of Siemens Healthineers (2020-2025)

Table 60. Siemens Healthineers Recent Developments

Table 61. Danaher Basic Information List

Table 62. Danaher Description and Business Overview

Table 63. Danaher Blood-based Biomarker Products, Services and Solutions

Table 64. Revenue (US$ Million) in Blood-based Biomarker Business of Danaher (2020-2025)

Table 65. Danaher Recent Developments

Table 66. Quidel Corporation Basic Information List

Table 67. Quidel Corporation Description and Business Overview

Table 68. Quidel Corporation Blood-based Biomarker Products, Services and Solutions

Table 69. Revenue (US$ Million) in Blood-based Biomarker Business of Quidel Corporation (2020-2025)

Table 70. Quidel Corporation Recent Developments

Table 71. Grifols Basic Information List

Table 72. Grifols Description and Business Overview

Table 73. Grifols Blood-based Biomarker Products, Services and Solutions

Table 74. Revenue (US$ Million) in Blood-based Biomarker Business of Grifols (2020-2025)

Table 75. Grifols Recent Developments

Table 76. Biocartis Basic Information List

Table 77. Biocartis Description and Business Overview

Table 78. Biocartis Blood-based Biomarker Products, Services and Solutions

Table 79. Revenue (US$ Million) in Blood-based Biomarker Business of Biocartis (2020-2025)

Table 80. Biocartis Recent Developments

Table 81. Vernalis Basic Information List

Table 82. Vernalis Description and Business Overview

Table 83. Vernalis Blood-based Biomarker Products, Services and Solutions

Table 84. Revenue (US$ Million) in Blood-based Biomarker Business of Vernalis (2020-2025)

Table 85. Vernalis Recent Developments

Table 86. Labcorp Drug Development Basic Information List

Table 87. Labcorp Drug Development Description and Business Overview

Table 88. Labcorp Drug Development Blood-based Biomarker Products, Services and Solutions

Table 89. Revenue (US$ Million) in Blood-based Biomarker Business of Labcorp Drug Development (2020-2025)

Table 90. Labcorp Drug Development Recent Developments

Table 91. Key Raw Materials Lists

Table 92. Raw Materials Key Suppliers Lists

Table 93. Blood-based Biomarker Downstream Customers

Table 94. Blood-based Biomarker Distributors List

Table 95. Research Programs/Design for This Report

Table 96. Key Data Information from Secondary Sources

Table 97. Key Data Information from Primary Sources

List of Figures

Figure 1. Blood-based Biomarker Product Picture

Figure 2. Global Blood-based Biomarker Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Blood-based Biomarker Sales Value (2020-2031) & (US$ Million)

Figure 4. Blood-based Biomarker Report Years Considered

Figure 5. Global Blood-based Biomarker Players Revenue Ranking (2024) & (US$ Million)

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Blood-based Biomarker Revenue in 2024

Figure 7. Blood-based Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 8. Next Generation Sequencing Picture

Figure 9. Mass Spectrometry Picture

Figure 10. Liquid Biopsy Technologies Picture

Figure 11. Global Blood-based Biomarker Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 12. Global Blood-based Biomarker Sales Value Market Share by Type, 2024 & 2031

Figure 13. Product Picture of Hospital

Figure 14. Product Picture of Diagnostic Centers

Figure 15. Product Picture of Research Labs

Figure 16. Global Blood-based Biomarker Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 17. Global Blood-based Biomarker Sales Value Market Share by Application, 2024 & 2031

Figure 18. North America Blood-based Biomarker Sales Value (2020-2031) & (US$ Million)

Figure 19. North America Blood-based Biomarker Sales Value by Country (%), 2024 VS 2031

Figure 20. Europe Blood-based Biomarker Sales Value, (2020-2031) & (US$ Million)

Figure 21. Europe Blood-based Biomarker Sales Value by Country (%), 2024 VS 2031

Figure 22. Asia Pacific Blood-based Biomarker Sales Value, (2020-2031) & (US$ Million)

Figure 23. Asia Pacific Blood-based Biomarker Sales Value by Region (%), 2024 VS 2031

Figure 24. South America Blood-based Biomarker Sales Value, (2020-2031) & (US$ Million)

Figure 25. South America Blood-based Biomarker Sales Value by Country (%), 2024 VS 2031

Figure 26. Middle East & Africa Blood-based Biomarker Sales Value, (2020-2031) & (US$ Million)

Figure 27. Middle East & Africa Blood-based Biomarker Sales Value by Country (%), 2024 VS 2031

Figure 28. Key Countries/Regions Blood-based Biomarker Sales Value (%), (2020-2031)

Figure 29. United States Blood-based Biomarker Sales Value, (2020-2031) & (US$ Million)

Figure 30. United States Blood-based Biomarker Sales Value by Type (%), 2024 VS 2031

Figure 31. United States Blood-based Biomarker Sales Value by Application (%), 2024 VS 2031

Figure 32. Europe Blood-based Biomarker Sales Value, (2020-2031) & (US$ Million)

Figure 33. Europe Blood-based Biomarker Sales Value by Type (%), 2024 VS 2031

Figure 34. Europe Blood-based Biomarker Sales Value by Application (%), 2024 VS 2031

Figure 35. China Blood-based Biomarker Sales Value, (2020-2031) & (US$ Million)

Figure 36. China Blood-based Biomarker Sales Value by Type (%), 2024 VS 2031

Figure 37. China Blood-based Biomarker Sales Value by Application (%), 2024 VS 2031

Figure 38. Japan Blood-based Biomarker Sales Value, (2020-2031) & (US$ Million)

Figure 39. Japan Blood-based Biomarker Sales Value by Type (%), 2024 VS 2031

Figure 40. Japan Blood-based Biomarker Sales Value by Application (%), 2024 VS 2031

Figure 41. South Korea Blood-based Biomarker Sales Value, (2020-2031) & (US$ Million)

Figure 42. South Korea Blood-based Biomarker Sales Value by Type (%), 2024 VS 2031

Figure 43. South Korea Blood-based Biomarker Sales Value by Application (%), 2024 VS 2031

Figure 44. Southeast Asia Blood-based Biomarker Sales Value, (2020-2031) & (US$ Million)

Figure 45. Southeast Asia Blood-based Biomarker Sales Value by Type (%), 2024 VS 2031

Figure 46. Southeast Asia Blood-based Biomarker Sales Value by Application (%), 2024 VS 2031

Figure 47. India Blood-based Biomarker Sales Value, (2020-2031) & (US$ Million)

Figure 48. India Blood-based Biomarker Sales Value by Type (%), 2024 VS 2031

Figure 49. India Blood-based Biomarker Sales Value by Application (%), 2024 VS 2031

Figure 50. Blood-based Biomarker Industrial Chain

Figure 51. Blood-based Biomarker Manufacturing Cost Structure

Figure 52. Channels of Distribution (Direct Sales, and Distribution)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

Figure 55. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which region is expected to have the highest market share? zhanKai

For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 10.4% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.

What is the annual compound growth rate of the global Blood-based Biomarker market size from 2025 to 2031? shouQi

What was the global market size of Blood-based Biomarker in 2025? shouQi

What was the global market size of Blood-based Biomarker in 2031? shouQi

Which companies rank high in the global Blood-based Biomarker market? shouQi

Related Reports

Global Blood-based Biomarker Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Blood-based Biomarker market is projected to grow from US$ 2015 million in 2025 to US$ 3977 million by 2032, at a CAGR of 10.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-11
Pages: 140
USD 4900.00
(Single User License)
Global Blood-based Biomarker Market Research Report 2026
The global Blood-based Biomarker market was valued at US$ 2015 million in 2025 and is anticipated to reach US$ 3977 million by 2032, at a CAGR of 10.4% from 2026 to 2032.
Published Date: 2026-03-11
Pages: 116
USD 2900.00
(Single User License)
Global Blood-based Biomarker Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Blood-based Biomarker market size was US$ 2015 million in 2025 and is forecast to reach a readjusted size of US$ 3977 million by 2032 with a CAGR of 10.4% during the forecast period 2026-2032.
Published Date: 2026-03-11
Pages: 97
USD 4250.00
(Single User License)
Blood-based Biomarker - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Blood-based Biomarker was estimated to be worth US$ 2015 million in 2025 and is projected to reach US$ 3977 million, growing at a CAGR of 10.4% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 104
USD 3950.00
(Single User License)
Global Blood-based Biomarker Market Insights, Forecast to 2031
The global Blood-based Biomarker market is projected to grow from US$ 2015 million in 2025 to US$ 3638 million by 2031, at a Compound Annual Growth Rate (CAGR) of 10.4% during the forecast period.
Published Date: 2025-03-28
Pages: 143
USD 4900.00
(Single User License)
Global Blood-based Biomarker Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Blood-based Biomarker market size was US$ 1867 million in 2024 and is forecast to a readjusted size of US$ 3638 million by 2031 with a CAGR of 10.4% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 92
USD 4250.00
(Single User License)
Global Blood-based Biomarker Market Research Report 2025
The global market for Blood-based Biomarker was valued at US$ 1867 million in the year 2024 and is projected to reach a revised size of US$ 3638 million by 2031, growing at a CAGR of 10.4% during the forecast period.
Published Date: 2025-03-28
Pages: 85
USD 2900.00
(Single User License)

Global Blood-based Biomarker Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Blood-based Biomarker market is projected to grow from US$ 2015 million in 2025 to US$ 3977 million by 2032, at a CAGR of 10.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-11
Pages: 140
USD 4900.00 (Single User License)
Global Blood-based Biomarker Market Research Report 2026
The global Blood-based Biomarker market was valued at US$ 2015 million in 2025 and is anticipated to reach US$ 3977 million by 2032, at a CAGR of 10.4% from 2026 to 2032.
Published: 2026-03-11
Pages: 116
USD 2900.00 (Single User License)
Global Blood-based Biomarker Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Blood-based Biomarker market size was US$ 2015 million in 2025 and is forecast to reach a readjusted size of US$ 3977 million by 2032 with a CAGR of 10.4% during the forecast period 2026-2032.
Published: 2026-03-11
Pages: 97
USD 4250.00 (Single User License)
Blood-based Biomarker - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Blood-based Biomarker was estimated to be worth US$ 2015 million in 2025 and is projected to reach US$ 3977 million, growing at a CAGR of 10.4% from 2026 to 2032.
Published: 2026-03-09
Pages: 104
USD 3950.00 (Single User License)
Global Blood-based Biomarker Market Insights, Forecast to 2031
The global Blood-based Biomarker market is projected to grow from US$ 2015 million in 2025 to US$ 3638 million by 2031, at a Compound Annual Growth Rate (CAGR) of 10.4% during the forecast period.
Published: 2025-03-28
Pages: 143
USD 4900.00 (Single User License)
Global Blood-based Biomarker Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Blood-based Biomarker market size was US$ 1867 million in 2024 and is forecast to a readjusted size of US$ 3638 million by 2031 with a CAGR of 10.4% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 92
USD 4250.00 (Single User License)
Global Blood-based Biomarker Market Research Report 2025
The global market for Blood-based Biomarker was valued at US$ 1867 million in the year 2024 and is projected to reach a revised size of US$ 3638 million by 2031, growing at a CAGR of 10.4% during the forecast period.
Published: 2025-03-28
Pages: 85
USD 2900.00 (Single User License)